Tod Smeal - Jan 10, 2022 Form 3 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Chief Scientific Officer
Signature
/s/ Tod Smeal
Stock symbol
CRDF
Transactions as of
Jan 10, 2022
Transactions value $
$0
Form type
3
Date filed
1/14/2022, 12:34 PM
Next filing
Mar 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CRDF Stock Options Jan 10, 2022 Common Stock 275K $6.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 68,772 of the Options vest on January 10, 2023 and 5,731 vest monthly for 36 months beginning on February 10, 2023, provided the Optionee on the vesting date continues to provide services to the Company or an Affiliate.